Elanco Animal Health Incorporated Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount
Elanco Animal Health Incorporated (ELAN) reported Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount of $32.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings · last filed 2026-02-24
- Elanco Animal Health Incorporated effective income tax rate reconciliation, repatriation of foreign earnings, amount for fiscal 2025 was $32.00M.
- Elanco Animal Health Incorporated effective income tax rate reconciliation, repatriation of foreign earnings, amount for fiscal 2018 was $9.00M, a 114.29% increase from fiscal 2017.
- Elanco Animal Health Incorporated effective income tax rate reconciliation, repatriation of foreign earnings, amount for fiscal 2017 was $4.20M, a 75.00% increase from fiscal 2016.
- Elanco Animal Health Incorporated effective income tax rate reconciliation, repatriation of foreign earnings, amount for fiscal 2016 was $2.40M.
| Period end | Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount 12 month |
|---|---|
| 2025-12-31 | $32.00M 10-K · filed 2026-02-24 |
| 2018-12-31 | $9.00M 10-K · filed 2019-02-20 |
| 2017-12-31 | $4.20M 10-K · filed 2019-02-20 |
| 2016-12-31 | $2.40M 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |